Price movement over the last 24 hours
ARK Genomic Revolution ETF vs SPDR Gold Trust — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while SPDR Gold Trust trades at $372.81. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals.
| ARKG | GLD | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $495.90 |
52-Week Low | $23.09 | $300.96 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
GLD trades at $376.91, down 0.34% on the day, with a bearish technical signal driven by moving averages. The stock lacks standard financial ratios (P/E, P/S, P/B, ROE) as it is an ETF tracking gold. Recent news highlights gold's 25% decline from highs, central bank buying support, and mixed sentiment ahead of CPI data and Federal Reserve policy cues, keeping prices range-bound near $4,100/oz equivalents.
Outlook hinges on macroeconomic factors: inflation data and Fed policy may test support levels, while geopolitical risks and central bank demand provide buffers. Risks include prolonged rate hikes pressuring gold, but long-term bullish fundamentals persist. Investors face volatility with no clear near-term catalyst for breakout.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →